Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: Results of a randomized prospective multicenter clinical trial

被引：0
|
作者：
Waltregny, D
Boca, P
Nicolas, H
Youssef, E
Jeukenne, M
Bouffioux, C
Coppens, L
Andrianne, R
Bonnet, P
De Leval, J
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [31] GOSERELIN VERSUS ORCHIECTOMY IN THE TREATMENT OF ADVANCED PROSTATE-CANCER - FINAL RESULTS OF A RANDOMIZED TRIAL
    VOGELZANG, NJ
    CHODAK, GW
    SOLOWAY, MS
    BLOCK, NL
    SCHELLHAMMER, PF
    SMITH, JA
    CAPLAN, RJ
    KENNEALEY, GT
    UROLOGY, 1995, 46 (02) : 220 - 226
  • [32] A survey to determine patients' (pts) opinions of a clinical trial (CT) comparing intermittent (int) versus continuous (cont) androgen receptor signaling inhibitor (ARSi) therapy for the treatment of advanced prostate cancer.
    Phillips, Cameron
    Delos Santos, Seanthel
    Mason, Robert
    Emmenegger, Urban
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [33] Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis.: Results of a prospective, randomized clinical trial
    Capussotti, L
    Nuzzo, G
    Polastri, R
    Giuliante, F
    Muratore, A
    Giovannini, I
    HEPATO-GASTROENTEROLOGY, 2003, 50 (52) : 1073 - 1077
  • [34] Randomized trial of enzalutamide versus bicalutamide in combination with androgen deprivation in metastatic hormone sensitive prostate cancer: A Prostate Cancer Clinical Trials Consortium trial.
    Vaishampayan, Ulka N.
    Heilbrun, Lance K.
    Monk, Paul
    Tejwani, Sheela
    Sonpavde, Guru
    Smith, Daryn
    Jasti, Pallavi
    Dobson, Kimberlee
    Heath, Elisabeth I.
    Cher, Michael L.
    Chinni, Sreenivasa
    Fontana, Joseph A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [35] Effect of docetaxel added to bicalutamide in Hormone-Naive non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
    Josefsson, Andreas
    Jellvert, Asa
    Holmberg, Erik
    Brasso, Klaus
    Meidahl Petersen, Peter
    Aaltomaa, Sirpa
    Luukkaa, Marjaana
    Verhagen, Paul
    de Wit, Ronald
    Ahlgren, Goeran
    Andren, Ove
    Castellanos, Enrique
    Seke, Mihalj
    Widmark, Anders
    Damber, Jan-Erik
    ACTA ONCOLOGICA, 2023, 62 (04) : 372 - 380
  • [36] Intermittent androgen-deprivation therapy in the management of castrate-resistant prostate cancer (CRPCa): Results of a multi-institutional randomized prospective clinical trial
    Organ, M.
    Wood, L.
    Wilke, D.
    Skedgel, C.
    Thompson, K.
    North, S.
    Cheng, T.
    Winch, S.
    Rendon, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [37] Tolerability and efficacy of anti-androgen manipulation versus taxotere and anti-androgen manipulation in patients with hormone-naive, high-risk/metastatic prostate cancer: A phase II, open-labeled, randomized study
    Pedley, I. D.
    Frew, J. A.
    Wilson, J. M.
    Razak, A. R. Abdul
    Azzabi, A.
    McMenemin, R.
    Stockley, J.
    Soomro, N.
    Durkan, G.
    Leung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [38] Internet of things-based lifestyle intervention for prostate cancer patients on androgen deprivation therapy: a prospective, multicenter, randomized trial
    Park, Yong Hyun
    Lee, Jong In
    Lee, Ji Youl
    Cheong, In Yae
    Hwang, Ji Hye
    Seo, Seong Il
    Lee, Kang Hyun
    Yoo, Ji Sung
    Chung, Seung Hyun
    So, Yekyeong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5496 - 5507
  • [39] A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naive prostate cancer (mHNPC): ZZFIRST.
    Mateo, Joaquin
    Borque, Angel
    Castellano, Daniel E.
    Castro, Elena
    Climent Duran, Miguel Angel A.
    Font, Albert
    Lorente, David
    Mellado, Begona
    Rodriguez-Vida, Alejo
    Cuadras, Merce
    Planas, Jacques
    Casanova Salas, Irene
    Cordoba, Sarai
    Gonzalez, Lucila
    Martinez de Falcon, Marta
    Fernandez, Melissa
    Sampayo-Cordero, Miguel
    Malfettone, Andrea
    Perez-Lopez, Raquel
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [40] Safety results of a phase III trial evaluating ADT plus docetaxel versus ADT alone in hormone-naive metastatic prostate cancer patients (GETUG-AFU 15/0403)
    Latorzeff, I.
    Esterni, B.
    Habibian, M.
    Delplanque, G.
    Theodore, C.
    Baciuchka, M.
    Dauba, J.
    Laguerre, B.
    Krakowski, I.
    Gravis, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345